{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:32:00Z","timestamp":1791955920136,"version":"4.3.4"},"reference-count":15,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1297\/cpe.25.91","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T18:06:54Z","timestamp":1468951614000},"page":"91-98","source":"Crossref","is-referenced-by-count":2,"title":["Potential utility of cinacalcet as a treatment for <i>CDC73<\/i>-related primary hyperparathyroidism: a case report"],"prefix":"10.1297","volume":"25","author":[{"given":"Takeshi","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama, Japan"},{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Muroya","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hanakawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumimasa","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Child Neurology, Kanagawa Children\u2019s Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Nozawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kanagawa Children\u2019s Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Masudo","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Asakura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Carpten, JD, Robbins, CM, Villablanca, A, Forsberg, L, Presciuttini, S, Bailey-Wilson, J, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 2002;32: 676\u201380.","DOI":"10.1038\/ng1048"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Shattuck, TM, V\u00e4lim\u00e4ki, S, Obara, T, Gaz, RD, Clark, OH, Shoback, D, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003;349: 1722\u20139.","DOI":"10.1056\/NEJMoa031237"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cetani, F, Pardi, E, Borsari, S, Viacava, P, Dipollina, G, Cianferotti, L, et al. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 2004;89: 5583\u201391.","DOI":"10.1210\/jc.2004-0294"},{"key":"4","unstructured":"4. Jackson, MA, Hu, MI, Perrier, ND, Waguespack, SG. CDC73-related disorders. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K (ed) GeneReviews\u00ae [Internet][updated 2015 Jan 15]. Seattle (WA): University of Washington, Seattle: 1993-2015 http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK3789\/."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Iacobone, M, Masi, G, Barzon, L, Porzionato, A, Macchi, V, Ciarleglio, FA, et al. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg 2009;394: 817\u201325.","DOI":"10.1007\/s00423-009-0511-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schwarz, P, Body, JJ, C\u00e1p, J, Hofbauer, LC, Farouk, M, Gessl, A, et al. The PRIMARA study: a prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice. Eur J Endocrinol 2014;171: 727\u201335.","DOI":"10.1530\/EJE-14-0355"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ballinger, AE, Palmer, SC, Nistor, I, Craig, JC, Strippoli, GF. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev 2014;12: CD006254.","DOI":"10.1002\/14651858.CD006254.pub2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Marcocci, C, Bollerslev, J, Khan, AA, Shoback, DM. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab 2014;99: 3607\u201318.","DOI":"10.1210\/jc.2014-1417"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gannon, AW, Monk, HM, Levine, MA. Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review. J Clin Endocrinol Metab 2014;99: 7\u201311.","DOI":"10.1210\/jc.2013-2834"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Silverberg, SJ, Rubin, MR, Faiman, C, Peacock, M, Shoback, DM, Smallridge, RC, et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 2007;92: 3803\u20138.","DOI":"10.1210\/jc.2007-0585"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Saponaro, F, Faggiano, A, Grimaldi, F, Borretta, G, Brandi, ML, Minisola, S, et al. Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group. Clin Endocrinol (Oxf) 2013;79: 20\u20136.","DOI":"10.1111\/cen.12108"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Filopanti, M, Verga, U, Ermetici, F, Olgiati, L, Eller-Vainicher, C, Corbetta, S, et al. MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly. Eur J Endocrinol 2012;167: 157\u201364.","DOI":"10.1530\/EJE-12-0117"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tonelli, F, Marcucci, T, Fratini, G, Tommasi, MS, Falchetti, A, Brandi, ML. Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?Ann Surg 2007;246: 1075\u201382.","DOI":"10.1097\/SLA.0b013e31811f4467"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. St\u00e5lberg, P, Carling, T. Familial parathyroid tumors: diagnosis and management. World J Surg 2009;33: 2234\u201343.","DOI":"10.1007\/s00268-009-9924-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mehta, A, Patel, D, Rosenberg, A, Boufraqech, M, Ellis, RJ, Nilubol, N, et al. Hyperparathyroidism-jaw tumor syndrome: Results of operative management. Surgery 2014;156: 1315\u201324, discussion 1324\u20135.","DOI":"10.1016\/j.surg.2014.08.004"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/25\/3\/25_2015-0027\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T14:45:32Z","timestamp":1498315532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/25\/3\/25_2015-0027\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.25.91","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}